Latest filing published 03 Apr 2017 for Cipher Pharmaceuticals Inc..
No signal scores available.
All filings by Linda Melanie Angaritis on record concern Cipher Pharmaceuticals Inc. We count 3 filings; the first trade dates from 15 March 2016 and the latest from 15 March 2017.
Every open-market trade on record is a sale: 1 sale. The totals exclude 1 filing filed without an amount. Other entries cover 2 option exercises.
The record was last updated on 3 April 2017 with an option exercise in Cipher Pharmaceuticals Inc. Filings reach the SEDI feed a median of 5 days after the trade. The shorter that gap, the sooner other investors can see what insiders have done. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations